WHO ICTRP trial
Drug proving of homoeopathic drug substance
CTRI/2019/07/020033 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2019/07/020033 |
|---|---|
| Public title | Drug proving of homoeopathic drug substance |
| Scientific title | Homoeopathic drug proving: Randomized double blind placebo controlled trial for drug code 141 |
| Primary sponsor | Central Council for Research in Homoeopathy |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | India |
| Interventions | Intervention1: Drug code 141: To be administered in 6C, 12C, 30C and 200C potencies. 12 doses for each potency, Frequency- Four times a day, Route of administration- Oral Control Intervention1: Placebo: Optically identical to the… |
| Registration date | Apr 7, 2019 |
| Target size | 120 |
| Secondary IDs | Nil |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: